SCHEMBL22396403

SCHEMBL22396403

CCCOC(=O)c1cc2ccc(O)cc2cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
TSHR P16473 3/20 0.53
ESR1 P03372 2/20 0.53
CHRM1 P11229 1/20 0.53
SLC6A2 P23975 1/20 0.53
KDR P35968 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
MAPT P10636 6/20 0.49
SMN1; SMN2 Q16637 5/20 0.49
GABRP O00591 3/20 0.49
GABRD O14764 3/20 0.49
GABRA1 P14867 3/20 0.49
GABRB1 P18505 3/20 0.49
GABRG2 P18507 3/20 0.49
GABRB3 P28472 3/20 0.49
GABRA5 P31644 3/20 0.49
GABRA3 P34903 3/20 0.49
GABRA2 P47869 3/20 0.49
GABRB2 P47870 3/20 0.49
GABRA4 P48169 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28680173 0.84 GABRP (0.59) ALDH1A1TSHRMAPTSMN1; SMN2GABRP
SCHEMBL1535240 0.81 LCK (0.60) ALDH1A1MAPTGABRPGABRDGABRA1
SCHEMBL22493056 0.81 MAPT (0.50) ALDH1A1TSHRMAPTSMN1; SMN2GABRP
SCHEMBL5599708 0.78 ESR1 (0.70) ALDH1A1TSHRESR1CHRM1SLC6A2
SCHEMBL28410064 0.77 HIF1A (0.43) ALDH1A1TSHRMAPTSMN1; SMN2GABRP
SCHEMBL27449890 0.76 TSHR (0.60) ALDH1A1TSHRESR1TDP1MAPT
SCHEMBL546168 0.75 LCK (0.60) ALDH1A1ESR1MAPTGABRPGABRD
SCHEMBL8068826 0.74 SERPINE1 (0.55) ALDH1A1TSHRESR1CHRM1SLC6A2
SCHEMBL13610176 0.74 ALDH1A1 (0.56) ALDH1A1TSHRESR1TDP1MAPT
SCHEMBL21200187 0.74 MEN1 (0.43) ALDH1A1ESR1MAPTKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3704113-A1 BRIDGED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS Bristol-Myers Squibb Company (US) 2020-09-09 EP disclosed